299 related articles for article (PubMed ID: 10371488)
1. The NOD mouse model of type 1 diabetes: as good as it gets?
Atkinson MA; Leiter EH
Nat Med; 1999 Jun; 5(6):601-4. PubMed ID: 10371488
[No Abstract] [Full Text] [Related]
2. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
Yang Y; Santamaria P
J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
[No Abstract] [Full Text] [Related]
3. [An animal model of type 1 diabetes (NOD mice)].
Nagata M
Nihon Rinsho; 2002 Aug; 60 Suppl 8():25-32. PubMed ID: 12355754
[No Abstract] [Full Text] [Related]
4. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.
Apostolou I; Von Boehmer H
J Autoimmun; 2004 Mar; 22(2):111-4. PubMed ID: 14987738
[No Abstract] [Full Text] [Related]
5. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse.
Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Kobayashi M; Hiromine Y; Makino S; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():114-7. PubMed ID: 17130540
[TBL] [Abstract][Full Text] [Related]
6. Animal models of insulin-dependent diabetes.
Liu E; Yu L; Moriyama H; Eisenbarth GS
Methods Mol Med; 2004; 102():195-212. PubMed ID: 15286387
[TBL] [Abstract][Full Text] [Related]
7. Cellular expression requirements for inhibition of type 1 diabetes by a dominantly protective major histocompatibility complex haplotype.
Chen YG; Silveira PA; Osborne MA; Chapman HD; Serreze DV
Diabetes; 2007 Feb; 56(2):424-30. PubMed ID: 17259387
[TBL] [Abstract][Full Text] [Related]
8. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
9. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
Yoshida K; Kikutani H
Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
[TBL] [Abstract][Full Text] [Related]
10. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.
Haskins K
J Autoimmun; 2004 Mar; 22(2):107-9. PubMed ID: 14987737
[No Abstract] [Full Text] [Related]
12. MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysis.
Fujisawa T; Ikegami H; Noso S; Yamaji K; Nojima K; Babaya N; Itoi-Babaya M; Hiromine Y; Kobayashi M; Makino S; Ogihara T
Ann N Y Acad Sci; 2006 Oct; 1079():118-21. PubMed ID: 17130541
[TBL] [Abstract][Full Text] [Related]
13. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells.
Mariño E; Batten M; Groom J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2008 Feb; 57(2):395-404. PubMed ID: 18025414
[TBL] [Abstract][Full Text] [Related]
14. Insulin--a primary autoantigen in type 1 diabetes?
Wong FS
Trends Mol Med; 2005 Oct; 11(10):445-8. PubMed ID: 16150642
[TBL] [Abstract][Full Text] [Related]
15. [Etiopathogenic bases of insulin-dependent diabetes].
Corbi C; Vimont S; Benoist JF; Legrand A; Lemonnier A
Ann Biol Clin (Paris); 1994; 52(6):499-504. PubMed ID: 7856954
[No Abstract] [Full Text] [Related]
16. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.
Boudaly S; Morin J; Berthier R; Marche P; Boitard C
Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018
[TBL] [Abstract][Full Text] [Related]
17. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Cardell SL
Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
[TBL] [Abstract][Full Text] [Related]
18. (Pro)insulin-specific regulatory T cells.
Harrison LC; Solly NR; Martinez NR
Novartis Found Symp; 2003; 252():132-41; discussion 141-5, 203-10. PubMed ID: 14609216
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune diabetes mellitus--much progress, but many challenges.
McDevitt HO; Unanue ER
Adv Immunol; 2008; 100():1-12. PubMed ID: 19111161
[No Abstract] [Full Text] [Related]
20. Type 1 diabetes: focus on prevention.
von Boehmer H
Nat Med; 2004 Aug; 10(8):783-4. PubMed ID: 15286776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
